SEARCH RESULTS FOR: "Tag: SGMO"
REFINE YOUR SEARCH:
RECENT
Last Month(1)
ARTICLES/BLOGS
2019(3)
2018(4)
2017(5)
2015(1)
CATEGORIES
Analyst Update(3)
Analyst Upgrades(1)
Intraday Option Activity(1)
Quantitative Analysis(2)
Stocks On the Move(7)
Technical Analysis(1)
Sangamo Therapeutics Bull Gap Fuels Hot Options Trading
https://www.schaeffersresearch.com/content/options/2019/04/02/sangamo-therapeutics-bull-gap-fuels-hot-options-trading
4/2/2019 12:43 PM
The shares of Sangamo Therapeutics Inc (NASDAQ:SGMO) are on fire, after the California-based biotech reported positive data in a phase 1/2 study for its gene therapy hemophilia treatment that's being...
Signal Says Sell This Biotech Stock
https://www.schaeffersresearch.com/content/analysis/2019/03/12/signal-says-sell-this-biotech-stock
3/12/2019 12:23 PM
Biotech company Sangamo Therapeutics Inc (NASDAQ:SGMO) just named Jason Fontenot, Ph.D. as its Senior Vice President, Cell Therapy. Fontenot will be in charge of the genomic medicine concern's develo...
3 Stocks Down Sharply Today
https://www.schaeffersresearch.com/content/news/2019/02/07/3-stocks-down-sharply-today
2/7/2019 2:58 PM
Stocks are staring at stiff losses following fresh U.S.-China trade news. Among individual names making big moves lower are ePort parent USA Technologies, Inc. (NASDAQ:USAT), biotech Sangamo Therap...
3 Stocks Selling Off Today
https://www.schaeffersresearch.com/content/news/2018/09/05/3-stocks-selling-off-today
9/5/2018 2:53 PM
It's a mixed trading day on Wall Street, with the tech sector lagging on regulatory concerns. Among individual stocks making volatile moves are genome editing firm Sangamo Therapeutics Inc (NASDAQ:S...
Buy Calls On This Biotech
https://www.schaeffersresearch.com/content/analysis/2018/04/19/buy-calls-on-this-biotech
4/19/2018 1:15 PM
Biotech stock Sangamo Therapeutics Inc (NASDAQ:SGMO) touched a 17-year high of $27.50 on Feb. 22, after the company announced a $3 billion gene-editing deal with Gilead Sciences (GILD). Since then,...
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.
More About
Schaeffer's
Contact
Us
Partner Center